Vidar Hansson
Keine laufenden Positionen mehr
Profil
Vidar Hansson formerly worked at PCI Biotech Holding ASA, as Chief Executive Officer, Photocure ASA, as Chief Executive Officer, Lauras AS, as Chief Executive Officer, and Nordic Nanovector ASA, as Director.
Ehemalige bekannte Positionen von Vidar Hansson
| Unternehmen | Position | Ende |
|---|---|---|
| THOR MEDICAL | Direktor/Vorstandsmitglied | 01.07.2014 |
| PCI BIOTECH HOLDING ASA | Vorstandsvorsitzender | - |
| PHOTOCURE ASA | Vorstandsvorsitzender | - |
Lauras AS
 Lauras AS Miscellaneous Commercial ServicesCommercial Services Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| PCI BIOTECH HOLDING ASA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Lauras AS
Lauras AS Miscellaneous Commercial ServicesCommercial Services Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway. | Commercial Services |
